The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Texas Southern University
- Study ID
- NCT07413159
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pharmacists Only (Control Group) — OTHERMedication management and disease state counseling provided by a clinical pharmacist.
- Combined Intervention (Pharmacists + CHW Interventions) — OTHERParticipants receive CHW Individual patient assistance and group health workshops in addition to pharmacist interventions
Study Details
The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Americans, contributing to higher rates of cardiovascular disease and stroke. This project aims to improve clinical and behavioral outcomes through a 24-month intervention combining pharmacist-led counseling and Community Health Worker (CHW) support.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Apr 2026
- Primary completion
- May 31, 2028
- Completion
- May 31, 2030
Study Design
- Enrollment
- 480 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Pharmacist Only (Control Group)Participants receive usual hypertension care as per standard practice provided by a clinical pharmacists
- Experimental: Combined Intervention (Pharmacists + CHW Interventions)Participants receive both Pharmacist and CHW Counseling and Support
Primary Outcome Measure
Change in Systolic Blood Pressure [ Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months ]
Central Contacts
- Ivy 0 Poon, Pharm.D., M.S., BCPS713-313-4400
- Creaque C Tyler, PharmD, BCGP
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| 3100 Cleburne Street, Nabrit Science Building, | Houston | Texas | 77004 | Creaque C Tyler, PharmD, BCGP |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Blood Pressure Slopes and Ultrafiltration in Hemodialysis PatientsRecruiting · VA Office of Research and Development · Dallas, Texas
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)EARLY_PHASE1 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas